Dive in

We have our own point of view on the people, technologies, and conversations that will shape the future.

Tag results
Series A
Clear all
List view Grid view
Filters

Fighting Cancer Through Early Detection and New Therapies: Menlo’s Investments in Delfi and Opna

Cancer remains one of the leading causes of death in the U.S. and worldwide.

Experimentation for the Modern Growth Stack: Our Investment in Eppo
Finch: Bringing Data Interoperability to the Employment Sector
Investing in RelationalAI: Evolving the Modern Data Stack
Siteline: Attacking the Payments Problem in Construction
Our Investment in Parade: Unlocking Efficiency in Freight Brokerage

Why Menlo Ventures Invested in Julia Computing

Julia, the “Ju” in Jupyter, is a programming language that will soon be the standard in scientific computing, replacing MatLab and R, but is also popular on the server due to speed, multiple dispatch/type system, as well as a vast set of libraries that aid rapid application development.

Our Investment in Matik: Empowering the Enterprise With Data-Driven Documents

We’ve always been drawn to the world of possibility unlocked by automation—improving clunky and time-consuming workflows, enhancing productivity, freeing time

A New System of Record for the Enterprise: Our Investment in Vareto
Our Investment in Relyance AI: Bringing Real-Time Visibility to the Chaos of Data Compliance
Our Series A Investment in Prodigal: Humanizing the Lending Process and Ecosystem
Our Investment in Endgame

Why Menlo Ventures Invested in Edge Delta

Edge Delta is providing a whole new class of product and category—a complementary and incredibly necessary approach to observability—edge observability, a critical component of your new data stack.

Ophelia Health: Fighting the Opioid Epidemic by Making the Best Care Accessible
Our Investment in Riva Health: Building the Future of Cardiovascular Healthcare
Roadblocks and Opportunities in Electronic Healthcare Records: A Conversation with Particle Founder Troy Bannister
Fighting Cancer Through Early Detection and New Therapies: Menlo’s Investments in Delfi and Opna

Cancer remains one of the leading causes of death in the U.S. and worldwide.

January 11, 2023Johnny Hu
Experimentation for the Modern Growth Stack: Our Investment in Eppo

Experimentation is a key lever for growth, yet 90% of experimentation workflows today are manual.

June 22, 2022Naomi Pilosof Ionita
Finch: Bringing Data Interoperability to the Employment Sector

The fintech industry has grown exponentially in recent years with a next-gen cohort of outstanding entrepreneurs deconstructing monolithic legacy solutions.

June 8, 2022Croom Beatty and Matt Murphy
Investing in RelationalAI: Evolving the Modern Data Stack

RAI has created perhaps one of the most unique and powerful databases in the world.

April 26, 2022Tim Tully
Siteline: Attacking the Payments Problem in Construction

As repeat investors in the construction technology space, we have been vocal about the opportunities to build valuable companies in the category.

February 24, 2022Tyler Sosin
Our Investment in Parade: Unlocking Efficiency in Freight Brokerage

Below the surface of the freight industry lies a fragmented relationship between shippers, brokers, and carriers that makes the very movement of goods throughout the United States incredibly complex.

February 9, 2022Steve Sloane and Feyza Haskaraman
Why Menlo Ventures Invested in Julia Computing

Julia, the “Ju” in Jupyter, is a programming language that will soon be the standard in scientific computing, replacing MatLab and R, but is also popular on the server due to speed, multiple dispatch/type system, as well as a vast set of libraries that aid rapid application development.

January 25, 2022Tim Tully
Our Investment in Matik: Empowering the Enterprise With Data-Driven Documents

We’ve always been drawn to the world of possibility unlocked by automation—improving clunky and time-consuming workflows, enhancing productivity, freeing time to focus on higher-order problems. One area long plagued by...

October 13, 2021Naomi Pilosof Ionita and Grace Ge
A New System of Record for the Enterprise: Our Investment in Vareto

Digital transformation has swept through nearly every department across the enterprise. However, for all the significant tech innovation in recent years, financial planning and analysis (FP&A) teams have been sadly underserved.

October 1, 2021Naomi Pilosof Ionita
Our Investment in Relyance AI: Bringing Real-Time Visibility to the Chaos of Data Compliance

There has been a firestorm sparked by efforts across the globe to legislate consumer privacy, as well as increasingly sophisticated data attacks and public, embarrassing leaks.

September 15, 2021Matt Murphy
Our Series A Investment in Prodigal: Humanizing the Lending Process and Ecosystem

There is currently $15 trillion of consumer debt in the U.S. Lenders pay hundreds of billions of dollars to acquire customers, underwrite them, and then give them a loan. But then what?

July 22, 2021Croom Beatty
Our Investment in Endgame

To win in today’s market, startups must build smart from the ground up with efficient business models that drive growth.

July 13, 2021Naomi Pilosof Ionita
Why Menlo Ventures Invested in Edge Delta

Edge Delta is providing a whole new class of product and category—a complementary and incredibly necessary approach to observability—edge observability, a critical component of your new data stack.

June 25, 2021Tim Tully
Ophelia Health: Fighting the Opioid Epidemic by Making the Best Care Accessible

Opioid use disorder (OUD) is an epidemic that will define our generation. Roughly 90 million Americans use opioids and over 10 million misuse them.

April 22, 2021Greg Yap and Croom Beatty
Our Investment in Riva Health: Building the Future of Cardiovascular Healthcare

Nearly half of U.S. adults—108 million people—have high blood pressure, which is the #1 controllable risk for both heart disease and stroke, the two leading worldwide causes of death.

March 17, 2021Greg Yap
Roadblocks and Opportunities in Electronic Healthcare Records: A Conversation with Particle Founder Troy Bannister

As part of the 21st Century Cures Act, the White House established rules compelling payers and hospitals to make patient health data easily shareable by modern technology standards.

January 11, 2021Croom Beatty
loader.svg